1. Home
  2. TKNO vs TCI Comparison

TKNO vs TCI Comparison

Compare TKNO & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • TCI
  • Stock Information
  • Founded
  • TKNO 1996
  • TCI 1983
  • Country
  • TKNO United States
  • TCI United States
  • Employees
  • TKNO N/A
  • TCI N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • TCI Real Estate
  • Sector
  • TKNO Health Care
  • TCI Finance
  • Exchange
  • TKNO Nasdaq
  • TCI Nasdaq
  • Market Cap
  • TKNO 244.7M
  • TCI 239.2M
  • IPO Year
  • TKNO 2021
  • TCI N/A
  • Fundamental
  • Price
  • TKNO $4.92
  • TCI $28.05
  • Analyst Decision
  • TKNO Buy
  • TCI
  • Analyst Count
  • TKNO 2
  • TCI 0
  • Target Price
  • TKNO $5.00
  • TCI N/A
  • AVG Volume (30 Days)
  • TKNO 133.3K
  • TCI 2.7K
  • Earning Date
  • TKNO 11-07-2024
  • TCI 11-07-2024
  • Dividend Yield
  • TKNO N/A
  • TCI N/A
  • EPS Growth
  • TKNO N/A
  • TCI N/A
  • EPS
  • TKNO N/A
  • TCI 0.69
  • Revenue
  • TKNO $34,940,000.00
  • TCI $50,541,000.00
  • Revenue This Year
  • TKNO $3.22
  • TCI N/A
  • Revenue Next Year
  • TKNO $14.88
  • TCI N/A
  • P/E Ratio
  • TKNO N/A
  • TCI $40.18
  • Revenue Growth
  • TKNO N/A
  • TCI N/A
  • 52 Week Low
  • TKNO $1.16
  • TCI $26.91
  • 52 Week High
  • TKNO $5.46
  • TCI $43.40
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 55.60
  • TCI 45.10
  • Support Level
  • TKNO $4.47
  • TCI $26.91
  • Resistance Level
  • TKNO $4.93
  • TCI $28.69
  • Average True Range (ATR)
  • TKNO 0.40
  • TCI 0.64
  • MACD
  • TKNO -0.01
  • TCI 0.02
  • Stochastic Oscillator
  • TKNO 58.77
  • TCI 50.22

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: